Lamisil 1

Terbinafine, the active ingredient in Lamisil 1, is a allylamine antifungal presented as a topical formulation for cutaneous use. It is employed to treat dermatophyte infections of the skin, such as athlete’s foot, ringworm, and jock itch, in both adult and pediatric patients.

GNH USA supplies Lamisil 1 as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company ensures quality and regulatory compliance across EU and global markets. Products are shipped with appropriate documentation and temperature control where required.

Terbinafine is an allylamine antifungal used to treat superficial dermatophyte infections of the skin.

- Tinea pedis: reduces itching, scaling and erythema while eliminating the causative dermatophyte on the feet, leading to symptom relief and skin healing. - Tinea corporis: clears the characteristic ring‑shaped, erythematous lesions on the trunk or limbs by eradicating the fungal organism, restoring normal skin appearance. - Tinea cruris: treats fungal infection of the groin and inner thigh region, alleviating redness, itching and maceration, and promoting skin recovery.

Terbinafine may cause a range of adverse reactions, most of which are mild and reversible.

Common Side Effects: - Skin irritation: localized redness, burning, or itching at the application site, usually resolving after discontinuation. - Pruritus: generalized itching without visible rash, which may be intermittent and mild to moderate in intensity. - Dryness: peeling or flaking of treated skin, sometimes accompanied by mild scaling or tightness. - Headache: mild to moderate headache that may occur during treatment and typically subsides without intervention.

Serious or Rare Side Effects: - Hepatotoxicity: elevated liver enzymes or clinical hepatitis, which may present with jaundice, fatigue, or abdominal discomfort, requiring laboratory monitoring. - Severe allergic reaction: swelling, hives, or difficulty breathing indicative of anaphylaxis, necessitating immediate medical attention. - Blood disorders: neutropenia or agranulocytosis, which can impair immune function and increase infection risk, warranting blood count monitoring.

When using Terbinafine topical products, several precautionary measures should be observed to ensure safety and effectiveness.

- Avoid application on broken skin: do not apply to open wounds or irritated areas. - Limit exposure: wash hands thoroughly after each use to prevent accidental contact with eyes or mucous membranes. - Monitor for allergic reactions: discontinue use and seek medical advice if swelling, rash, or breathing difficulties develop. - Assess liver function: patients with pre‑existing liver disease should have baseline and periodic liver enzyme testing. - Store at ambient temperature: keep below 25°C in the original